Distinct Pathways, Shared Progress: Metabolic/Genetic Disorders & Biliary Physiology

Nov 09 2025
Convention Center: Room 145, Level 1
8:00 AM - 9:30 AM

World Class Speakers

Michael L Schilsky, MD, FAASLD
Moderator

Michael L Schilsky, MD, FAASLD

Yale University Medical Center
Wen-Xing Ding, MD, PhD, FAASLD
Moderator

Wen-Xing Ding, MD, PhD, FAASLD

University of Kansas Medical Center

Description

This session highlights innovations from molecular mechanisms to drug development and clinical trials in biliary physiology and genetic and metabolic conditions. This session will spotlight cholangiocyte biology from scaffolding to repair. Gain insight into mechanisms and therapautics for A1AT deficiency, Wilson Disease, and hemachromatosis. 

Objectives

  • 1. Evaluate emerging therapies for metabolic and genetic liver disease.
  • 2. Describe basic science mechanisms of cholangiocyte development and repair and implications for therapeutic targets.
  • 3. Integrate basic, translational, and clinical studies for treatment of biliary disorders and genetic/metabolic liver disease.